p57(KIP2), the second class of KIP family protein, is one of the negative r
egulators of the cell cycle. To elucidate the role of p57(KIP2) in colorect
al normal mucosa and cancer, we examined the expression of p57(KIP2) protei
n in 110 pairs of colorectal non-tumor and cancer tissues. Immunohistochemi
cal analysis showed that p57(KIP2) was weakly detected in the normal coloni
c epithelium and lymph follicles. A unique expression pattern of p57(KIP2)
was exclusively noted in the elastic fibers within the walls of relatively
large blood vessels (diameter >100 mum). In cancer tissues, p57(KIP2) prote
in was localized mainly in nuclei. Using the mean percentage of nuclear p57
(KIP2) expression (25%) as the cut-off value, we divided our cases into tho
se with high expression (n= 44, 40%) and low expression (n=66, 60%) of p57(
KIP2) among 110 colorectal cancer cases tested. The clinical and pathologic
al survey showed a significant correlation between low expression of p57(KI
P2) and large tumor size (p <0.05) or the presence of tumors in females (p<
0.01). Survival analysis showed that p57(KIP2) expression did not influence
prognosis. RT-PCR analysis was also performed using RNA extracts from 6 co
lorectal cancer tissues. When the levels of p57(KIP2) mRNAs were compared w
ith expression of p57(KIP2) protein, a clear correlation was found, suggest
ing that expression of the p57(KIP2) protein may be regulated at the transc
ription level. The present study revealed p57(KIP2) expression in colorecta
l cancer and suggests that p57(KlP2),ay not play a central role in the prog
ression of colorectal cancer.